by George Ciuciureanu | Apr 14, 2026 | Events, Health
Vancouver, Canada – April 14, 2026 – Augurex Life Sciences Corp., a leader in the development of autoimmune-based diagnostics, today announced that it has been named a semifinalist in the 2026 Disruptive Technology Award competition presented by the Association for...
by George Ciuciureanu | Apr 8, 2026 | Events, Health
Vancouver, Canada – April 8, 2026 – Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced it will attend and present new data at the British Society for Rheumatology (BSR) 2026 Annual Meeting, taking place April 28–30 in Glasgow,...
by George Ciuciureanu | Nov 17, 2025 | Events, Health
Augurex expands its 14-3-3eta test availability through a new partnership with Sonic Reference Laboratory, a division of Sonic Healthcare USA, to enhance the diagnosis and management of rheumatoid arthritis. The 14-3-3eta test will launch at Sonic Reference Laboratory...
by George Ciuciureanu | Oct 17, 2025 | Events, Health
Vancouver, Canada – October 17, 2025 – Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that it will be exhibiting at Booth 919 and presenting new data at the American College of Rheumatology (ACR) Convergence 2025, taking...
by George Ciuciureanu | Oct 15, 2025 | Events, Health
Augurex has partnered with MitogenDx to expand access to JOINTstat® testing across Canada, improving physician and patient access to advanced tools for rheumatoid arthritis (RA) diagnosis and monitoring. JOINTstat® is a Health Canada-approved Class II in vitro...
by George Ciuciureanu | Sep 24, 2025 | Events, Health
Augurex to present new data from clinical studies in an oral presentation and two poster presentations at ACR Convergence 2025, taking place October 24 – 29 in Chicago, IL. Professor Raj Sengupta will present new data in on the use of autoantibodies to 14-3-3eta in...
